BRISTOL MYERS SQUIBB Stock Price
$46.89 
Change:
0.35 0.38% Volume:
916,811
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 47.03 | Todays Low: 45.86 | Open: 46.54 | Last Close: 47
52 Wk High: 47.48 | 52 Wk Low: 30.65 | Todays Pivot: 46.70 | Pre market open: 46.96
Sector: Healthcare and Pharmaceuticals
Related Healthcare and Pharmaceuticals Companies
Above is a small selection of related companies to Bristol Myers Squibb which compete alongside BMY within the Healthcare and Pharmaceuticals sector.
Online News For Bristol Myers Squibb
|
Kumpf students in Clark donate to Bristol-Myers Squibb Children's Hospital - NJ.com
Wed, 22 May 2013 14:26Members of the National Junior Honor Society at the Carl H. Kumpf School in Clark donated $383.50 to the Bristol-Myers Squibb Children's Hospital in New Brunswick. The students raised the money by selling homemade chocolate covered pretzels after ...
|
|
Bristol-Myers Squibb lifted to buy at Citi - MarketWatch
Wed, 22 May 2013 06:37MADRID (MarketWatch) -- Bristol Myers Squibb Co. (NYSE:BMY) was upgraded to buy from neutral by analysts at Citi in a note that published May 22. Citi also lifted its price target to $55 from $33 and increased its 2017 earnings per share forecast by 31 ...
|
|
Bristol Myers Squibb Rating Increased to Buy at Citigroup (BMY) - Daily Political
Fri, 24 May 2013 15:34Bristol Myers Squibb Co. logo Citigroup upgraded shares of Bristol Myers Squibb (NYSE: BMY) from a neutral rating to a buy rating in a report issued on Wednesday, TheFlyOnTheWall.com reports. They currently have $55.00 target price on the stock, up ...
|
|
Reckitt Benkiser completes agreement with Bristol-Myers Squibb - ShareCast
Mon, 20 May 2013 06:52Reckitt Benkiser completes agreement with Bristol-Myers Squibb LONDON (SHARECAST) - Reckitt Benkiser has completed its agreement with Bristol-Myers Squibb Company (BMS), having received the necessary approvals. As reported back in February, ...
|
|
Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against ... - Insider Monkey (blog)
Mon, 20 May 2013 13:04Sprycel: Developed by Bristol Myers Squibb Co. (NYSE:BMY), Sprycel was approved in 2006 as a second-line treatment for patients who had Philadelphia chromosome-positive (Ph+) ALL or Ph+ CML, and had resistance to prior therapy. In trials, 42% of ...
|
|
Bristol-Myers Squibb drug study showed effectiveness against advanced ... - The Star-Ledger - NJ.com
Fri, 17 May 2013 15:50In the study, 52 patients were simultaneously treated with Bristol-Myers's melanoma drug Yervoy and nivolumab, its experimental therapy that targets the immune system in a different way. Tumors shrank in 40 percent of patients, and in 53 percent of ...
|
BMY Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Bristol Myers Squibb quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for BMY to choose from. Visit here to build your stock quote widget »
